Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ·Healthcare·Biotechnology
$429.47
+0.81%
Mkt Cap $111.71B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 12, 2026 | $3.18B | $3.19B | +0.18% | $5.11 | $5.03 | -1.57% | — | — |
| Q4 2025 Nov 3, 2025 | $3.06B | $3.08B | +0.55% | $4.57 | $4.80 | +5.03% | — | — |
| Q3 2025 Aug 4, 2025 | $2.91B | $2.96B | +2.01% | $4.29 | $4.52 | +5.36% | — | — |
| Q2 2025 May 5, 2025 | $2.86B | $2.77B | -3.20% | $4.25 | $4.06 | -4.47% | — | — |
| Q1 2025 Feb 10, 2025 | $2.78B | $2.91B | +4.59% | $4.02 | $3.98 | -1.00% | — | — |
| Q4 2024 Nov 4, 2024 | $2.69B | $2.77B | +3.22% | $4.14 | $4.38 | +5.80% | — | — |
| Q3 2024 Aug 1, 2024 | $2.66B | $2.63B | -1.09% | -$11.63 | -$12.83 | -10.32% | — | — |
| Q2 2024 May 6, 2024 | $2.58B | $2.69B | +4.10% | $4.06 | $4.76 | +17.24% | — | — |
| Q1 2024 Feb 5, 2024 | $2.51B | $2.52B | +0.19% | $4.10 | $4.20 | +2.44% | — | — |
| Q4 2023 Nov 6, 2023 | $2.50B | $2.48B | -0.59% | $3.97 | $4.08 | +2.77% | — | — |
| Q3 2023 Aug 1, 2023 | $2.42B | $2.49B | +3.05% | $3.88 | $3.89 | +0.26% | — | — |
| Q2 2023 May 1, 2023 | $2.34B | $2.37B | +1.62% | $3.00 | $3.05 | +1.67% | — | — |
| Q1 2023 Feb 7, 2023 | $2.30B | $2.30B | -0.09% | $3.51 | $3.76 | +7.12% | — | — |
| Q4 2022 Oct 27, 2022 | $2.23B | $2.33B | +4.68% | $3.64 | $4.01 | +10.16% | — | — |
| Q3 2022 Aug 4, 2022 | $2.13B | $2.20B | +3.02% | $3.48 | $3.60 | +3.45% | — | — |
| Q2 2022 May 5, 2022 | $2.07B | $2.10B | +1.09% | $3.49 | $3.52 | +0.86% | — | — |
| Q1 2022 Jan 26, 2022 | $2.00B | $2.07B | +3.50% | $3.30 | $3.37 | +2.12% | — | — |
| Q4 2021 Nov 2, 2021 | $1.85B | $1.98B | +7.47% | $3.08 | $3.56 | +15.58% | — | — |
| Q3 2021 Jul 29, 2021 | $1.72B | $1.79B | +4.38% | $2.69 | $3.11 | +15.61% | — | — |
| Q2 2021 Apr 29, 2021 | $1.66B | $1.72B | +3.82% | $2.69 | $2.98 | +10.78% | — | — |